bioAffinity Technologies (BIAF) Depreciation & Amortization - Total (2022 - 2026)
bioAffinity Technologies (BIAF) reported Depreciation & Amortization - Total of $24408.0 for Q1 2026, down 44.23% year-over-year from $43763.0 in Q1 2025, and down 34.96% quarter-over-quarter from $37529.0 in Q4 2025.
bioAffinity Technologies (BIAF) Depreciation & Amortization - Total (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 5 years of Depreciation & Amortization - Total data on file, last reported at $24408.0 in Q1 2026.
- Depreciation & Amortization - Total for Q1 2026 came in at $24408.0, down 44.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $151004.0 (down 9.73% YoY), and the FY2025 annual result was $170359.0, up 4.94% from the prior year.
- Depreciation & Amortization - Total slipped to $24408.0 in Q1 2026 per BIAF's latest filing, from $37529.0 in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $166284.0 in Q4 2023 and troughed at $800.0 in Q3 2022.
- A 5-year average of $41283.0 and a median of $40243.0 in 2024 frame the typical range for Depreciation & Amortization - Total.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization - Total soared 5536.88% in 2023, then slumped 74.26% in 2024.
- A 5-year view of Depreciation & Amortization - Total shows it stood at $7282.0 in 2022, then soared by 2183.49% to $166284.0 in 2023, then tumbled by 74.26% to $42806.0 in 2024, then declined by 12.33% to $37529.0 in 2025, then plunged by 34.96% to $24408.0 in 2026.
- Business Quant data shows BIAF's Depreciation & Amortization - Total at $24408.0 in Q1 2026, $37529.0 in Q4 2025, and $44599.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | 24,408.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,408.00 |
| Dec 31, 2025 | 37,529.00 |
| Sep 30, 2025 | 44,599.00 |
| Jun 30, 2025 | 44,468.00 |
| Mar 31, 2025 | 43,763.00 |
| Dec 31, 2024 | 42,806.00 |
| Sep 30, 2024 | 40,472.00 |
| Jun 30, 2024 | 40,243.00 |
| Mar 31, 2024 | 38,811.00 |
| Dec 31, 2023 | 166,284.00 |
| Sep 30, 2023 | 45,095.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 21,685.00 |
| Dec 31, 2022 | 7,282.00 |
| Sep 30, 2022 | 800.00 |